Free Newsletter
Survey looks at insulin injection pain, compliance
A survey of 502 regular insulin injectors and 301 professionals who treat them found, among other things, that at least 33 percent of patients experience dread when it comes to insulin injections and 47 percent said they would be more likely to comply with their drug regimen if they had tips for relieving injection discomfort. While Novo Nordisk, Eli Lilly, Sanofi Aventis are aggressively marketing insulin analogues to increase profits, Generex Biotechnology continues to study an alternative to injectable insulin. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





